Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Ran Chen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ran Chen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Navigating LATAM's Heartbeat: A Pure Global Deep Dive into Brazil's ANVISA & Mexico's COFEPRIS for Cardiac Monitoring & ECG Device Approval

3:12
 
Share
 

Manage episode 510217275 series 3684625
Content provided by Ran Chen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ran Chen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this episode of LATAM MedTech Insights, we delve into the rapidly expanding but notoriously complex market for cardiac monitoring and ECG devices in Latin America. We uncover why the region's high demand, fueled by demographic shifts and a growing healthcare sector in countries like Brazil, Mexico, and Argentina, presents both a massive opportunity and a significant challenge for global MedTech manufacturers. We explore the fragmented regulatory maze, moving beyond theory to discuss the practical realities of dealing with powerful agencies like Brazil's ANVISA and Mexico's COFEPRIS. We share a detailed case study of a European company whose launch of an innovative wearable ECG patch was delayed by 18 months due to a critical oversight in their Brazilian submission, illustrating how a small gap in local knowledge can lead to major commercial setbacks and loss of market share. 本期干货: - Why is Brazil’s ANVISA one of the most difficult regulatory bodies for cardiac device approval? - What are the three most common mistakes companies make when submitting technical files to COFEPRIS in Mexico? - How is the rise of telemedicine in Colombia changing the rules for market entry? - What specific in-country testing is required for ECG devices in Argentina that isn't required for a CE mark? - How can you design a single regulatory strategy to efficiently target Brazil, Mexico, and Colombia simultaneously? - What are the hidden costs associated with not having an experienced local registration holder? - How do reimbursement policies in public versus private healthcare sectors impact your product's profitability? The Latin American market holds immense potential, but navigating its regulatory and commercial landscape requires deep, localized expertise. At Pure Global, we transform these complex challenges into clear market access strategies. With our local experts in over 30 countries and advanced AI-driven data tools, we streamline the entire process from initial strategy to post-market surveillance. Don't let regulatory hurdles dictate your growth. Contact us to build your customized pathway into the LATAM market at [email protected] or visit us at https://pureglobal.com/.
  continue reading

47 episodes

Artwork
iconShare
 
Manage episode 510217275 series 3684625
Content provided by Ran Chen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ran Chen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this episode of LATAM MedTech Insights, we delve into the rapidly expanding but notoriously complex market for cardiac monitoring and ECG devices in Latin America. We uncover why the region's high demand, fueled by demographic shifts and a growing healthcare sector in countries like Brazil, Mexico, and Argentina, presents both a massive opportunity and a significant challenge for global MedTech manufacturers. We explore the fragmented regulatory maze, moving beyond theory to discuss the practical realities of dealing with powerful agencies like Brazil's ANVISA and Mexico's COFEPRIS. We share a detailed case study of a European company whose launch of an innovative wearable ECG patch was delayed by 18 months due to a critical oversight in their Brazilian submission, illustrating how a small gap in local knowledge can lead to major commercial setbacks and loss of market share. 本期干货: - Why is Brazil’s ANVISA one of the most difficult regulatory bodies for cardiac device approval? - What are the three most common mistakes companies make when submitting technical files to COFEPRIS in Mexico? - How is the rise of telemedicine in Colombia changing the rules for market entry? - What specific in-country testing is required for ECG devices in Argentina that isn't required for a CE mark? - How can you design a single regulatory strategy to efficiently target Brazil, Mexico, and Colombia simultaneously? - What are the hidden costs associated with not having an experienced local registration holder? - How do reimbursement policies in public versus private healthcare sectors impact your product's profitability? The Latin American market holds immense potential, but navigating its regulatory and commercial landscape requires deep, localized expertise. At Pure Global, we transform these complex challenges into clear market access strategies. With our local experts in over 30 countries and advanced AI-driven data tools, we streamline the entire process from initial strategy to post-market surveillance. Don't let regulatory hurdles dictate your growth. Contact us to build your customized pathway into the LATAM market at [email protected] or visit us at https://pureglobal.com/.
  continue reading

47 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play